This review examines the evolutionary basis of obstetric risk by integrating the obstetric dilemma (bipedal locomotion vs. large fetal cranium) with immunogenetic interactions between maternal uterine NK cell KIR receptors and fetal HLA-C molecules on invading trophoblast cells, and how these forces together shape birthweight and maternal/perinatal mortality.
Inhibitory KIR–HLA-C2 combinations impair trophoblast invasion and spiral artery remodeling, raising risk of pre-eclampsia and other great obstetrical syndromes (GOS), yet may boost maternal pathogen resistance; activating KIR–HLA interactions are protective against GOS but appear to confer weaker pathogen resistance — a balance consistent with stabilizing selection on both birthweight and immune genotypes.
This is a theoretical/review framework without new primary data or quantitative outcomes; causal claims between KIR–HLA combinations and specific clinical endpoints rely on existing association studies; speculative conclusions about how modern obstetric care will alter future allele frequencies are not empirically tested.
Clinicians managing high-risk pregnancies should be aware that pre-eclampsia and fetal growth restriction have deep immunogenetic roots — KIR/HLA-C genotyping may eventually refine risk stratification for great obstetrical syndromes. The evolutionary trade-offs described here suggest no single immunogenetic profile is uniformly optimal, complicating future precision-medicine approaches to obstetric care.
Explore related topics
